By Mike Adams, Health Ranger
24 January 2011
This is all happening because drug companies say they’re scaling back their research funding to find new drugs. This terrifies the U.S. government, apparently, which doesn’t recognize that scaling back drug company R&D is actually a good thing for America given how much economic damage and personal health damage is caused each year by Big Pharma’s dangerous drugs. So instead of letting the failing pharmaceutical market contract on its own, Big Government wants to artificially prop it up with taxpayer dollars in much the same way that the feds bailed out Wall Street’s rich banksters with trillions of dollars over the last two years.
The new government drug research center will operate under the National Institutes of Health (NIH) and be called the National Center for Advancing Translational Sciences. Dr. Francis Collins, director of the National Institutes of Health, says he hopes Congress will increase funding of the center to at least $1 billion annually.
The NIH, of course, is a revolving door for Big Pharma executives. Dr William Potter, for example, was formerly a researcher at the National Institute of Mental Health, after which he became the vice president of translational neuroscience at Merck. And the government money that goes into these so-called drug “discoveries” will only end up boosting the profits of drug companies rather than fundamentally improving the health of the American people. (More drugs does not equal better health. If anything it’s an inverse correlation: More drugs = more degenerative disease!)
Leave a Reply